Your browser doesn't support javascript.
loading
IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras-Mutant Lung Cancer.
Caetano, Mauricio S; Zhang, Huiyuan; Cumpian, Amber M; Gong, Lei; Unver, Nese; Ostrin, Edwin J; Daliri, Soudabeh; Chang, Seon Hee; Ochoa, Cesar E; Hanash, Samir; Behrens, Carmen; Wistuba, Ignacio I; Sternberg, Cinthya; Kadara, Humam; Ferreira, Carlos Gil; Watowich, Stephanie S; Moghaddam, Seyed Javad.
Afiliación
  • Caetano MS; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Zhang H; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Cumpian AM; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Gong L; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Unver N; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ostrin EJ; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Daliri S; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Chang SH; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ochoa CE; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hanash S; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Behrens C; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wistuba II; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sternberg C; Clinical Research Department, Brazilian Clinical Research Network (RNPCC), Rio de Janeiro, Brazil.
  • Kadara H; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ferreira CG; Clinical Research Department, Brazilian Clinical Research Network (RNPCC), Rio de Janeiro, Brazil.
  • Watowich SS; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. The University of Texas Graduate School of Biomedical Sciences, Houston, Texas.
  • Moghaddam SJ; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. The University of Texas Graduate School of Biomedical Sciences, Houston, Texas. smoghadd@mdanderson.org.
Cancer Res ; 76(11): 3189-99, 2016 06 01.
Article en En | MEDLINE | ID: mdl-27197187
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas p21(ras) / Interleucina-6 / Carcinoma de Pulmón de Células no Pequeñas / Microambiente Tumoral / Neoplasias Pulmonares / Anticuerpos Monoclonales / Mutación Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Res Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas p21(ras) / Interleucina-6 / Carcinoma de Pulmón de Células no Pequeñas / Microambiente Tumoral / Neoplasias Pulmonares / Anticuerpos Monoclonales / Mutación Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Res Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos